The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hepatitis A Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The global Hepatitis A Vaccine market size is expected to reach US$ 840.5 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Hepatitis A Vaccine in various end use industries. The expanding demands from the Government Institution, Private Sector and Other, are propelling Hepatitis A Vaccine market. Inactivated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Attenuated Vaccine segment is estimated at % CAGR for the next seven-year period.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%.
Asia-Pacific is the largest market, with a share over 35%, followed by North America and Europe , both have a share over 55 percent.
In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatitis A Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatitis A Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatitis A Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatitis A Vaccine covered in this report include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc.
The global Hepatitis A Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
Global Hepatitis A Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis A Vaccine market, Segment by Type:
Inactivated Vaccine
Live Attenuated Vaccine
Global Hepatitis A Vaccine market, by Application
Government Institution
Private Sector
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The global Hepatitis A Vaccine market size is expected to reach US$ 840.5 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Hepatitis A Vaccine in various end use industries. The expanding demands from the Government Institution, Private Sector and Other, are propelling Hepatitis A Vaccine market. Inactivated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Attenuated Vaccine segment is estimated at % CAGR for the next seven-year period.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%.
Asia-Pacific is the largest market, with a share over 35%, followed by North America and Europe , both have a share over 55 percent.
In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatitis A Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatitis A Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatitis A Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatitis A Vaccine covered in this report include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc.
The global Hepatitis A Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
Global Hepatitis A Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis A Vaccine market, Segment by Type:
Inactivated Vaccine
Live Attenuated Vaccine
Global Hepatitis A Vaccine market, by Application
Government Institution
Private Sector
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hepatitis A Vaccine Market Overview
1.1 Hepatitis A Vaccine Product Overview
1.2 Hepatitis A Vaccine Market Segment by Type
1.2.1 Inactivated Vaccine
1.2.2 Live Attenuated Vaccine
1.3 Global Hepatitis A Vaccine Market Size by Type
1.3.1 Global Hepatitis A Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Hepatitis A Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hepatitis A Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hepatitis A Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hepatitis A Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hepatitis A Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Type (2018-2023)
2 Global Hepatitis A Vaccine Market Competition by Company
2.1 Global Top Players by Hepatitis A Vaccine Sales (2018-2023)
2.2 Global Top Players by Hepatitis A Vaccine Revenue (2018-2023)
2.3 Global Top Players by Hepatitis A Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Hepatitis A Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hepatitis A Vaccine Market Competitive Situation and Trends
2.5.1 Hepatitis A Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hepatitis A Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Hepatitis A Vaccine Market
2.8 Key Manufacturers Hepatitis A Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hepatitis A Vaccine Status and Outlook by Region
3.1 Global Hepatitis A Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hepatitis A Vaccine Historic Market Size by Region
3.2.1 Global Hepatitis A Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Hepatitis A Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Hepatitis A Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hepatitis A Vaccine Forecasted Market Size by Region
3.3.1 Global Hepatitis A Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Hepatitis A Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hepatitis A Vaccine by Application
4.1 Hepatitis A Vaccine Market Segment by Application
4.1.1 Government Institution
4.1.2 Private Sector
4.1.3 Other
4.2 Global Hepatitis A Vaccine Market Size by Application
4.2.1 Global Hepatitis A Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Hepatitis A Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hepatitis A Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hepatitis A Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hepatitis A Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hepatitis A Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Application (2018-2023)
5 North America Hepatitis A Vaccine by Country
5.1 North America Hepatitis A Vaccine Historic Market Size by Country
5.1.1 North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hepatitis A Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Hepatitis A Vaccine Sales in Value by Country (2018-2023)
5.2 North America Hepatitis A Vaccine Forecasted Market Size by Country
5.2.1 North America Hepatitis A Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Hepatitis A Vaccine Sales in Value by Country (2024-2029)
6 Europe Hepatitis A Vaccine by Country
6.1 Europe Hepatitis A Vaccine Historic Market Size by Country
6.1.1 Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hepatitis A Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Hepatitis A Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Hepatitis A Vaccine Forecasted Market Size by Country
6.2.1 Europe Hepatitis A Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Hepatitis A Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Hepatitis A Vaccine by Region
7.1 Asia-Pacific Hepatitis A Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hepatitis A Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hepatitis A Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hepatitis A Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Hepatitis A Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hepatitis A Vaccine Sales in Value by Region (2024-2029)
8 Latin America Hepatitis A Vaccine by Country
8.1 Latin America Hepatitis A Vaccine Historic Market Size by Country
8.1.1 Latin America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hepatitis A Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hepatitis A Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Hepatitis A Vaccine Forecasted Market Size by Country
8.2.1 Latin America Hepatitis A Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hepatitis A Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Hepatitis A Vaccine by Country
9.1 Middle East and Africa Hepatitis A Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hepatitis A Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hepatitis A Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hepatitis A Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Hepatitis A Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hepatitis A Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Hepatitis A Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Hepatitis A Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Hepatitis A Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Sinovac
10.4.1 Sinovac Company Information
10.4.2 Sinovac Introduction and Business Overview
10.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sinovac Hepatitis A Vaccine Products Offered
10.4.5 Sinovac Recent Development
10.5 Zhejiang Pukang
10.5.1 Zhejiang Pukang Company Information
10.5.2 Zhejiang Pukang Introduction and Business Overview
10.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
10.5.5 Zhejiang Pukang Recent Development
10.6 Changchun Institute of Biological
10.6.1 Changchun Institute of Biological Company Information
10.6.2 Changchun Institute of Biological Introduction and Business Overview
10.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
10.6.5 Changchun Institute of Biological Recent Development
10.7 KM Biologics
10.7.1 KM Biologics Company Information
10.7.2 KM Biologics Introduction and Business Overview
10.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 KM Biologics Hepatitis A Vaccine Products Offered
10.7.5 KM Biologics Recent Development
10.8 IMBCAMS
10.8.1 IMBCAMS Company Information
10.8.2 IMBCAMS Introduction and Business Overview
10.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 IMBCAMS Hepatitis A Vaccine Products Offered
10.8.5 IMBCAMS Recent Development
10.9 Convac
10.9.1 Convac Company Information
10.9.2 Convac Introduction and Business Overview
10.9.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Convac Hepatitis A Vaccine Products Offered
10.9.5 Convac Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hepatitis A Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hepatitis A Vaccine Industrial Chain Analysis
11.4 Hepatitis A Vaccine Market Dynamics
11.4.1 Hepatitis A Vaccine Industry Trends
11.4.2 Hepatitis A Vaccine Market Drivers
11.4.3 Hepatitis A Vaccine Market Challenges
11.4.4 Hepatitis A Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hepatitis A Vaccine Distributors
12.3 Hepatitis A Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
